Pfizer’s vaccine, given in late pregnancy, allows moms-to-be to develop virus-fighting antibodies that pass to their fetus.
This image provided by Pfizer shows the RSV vaccine. U.S. regulators on Monday, Aug. 21, 2023, approved the first RSV vaccine for pregnant women so their babies will be born with protection against the scary respiratory infection.
The next step: The Centers for Disease Control and Prevention must issue recommendations for using the vaccine, named Abrysvo, during pregnancy. Last year’s RSV season was extremely harsh in the U.S., and it began sickening tots in the summer, far earlier than usual. If enough pregnant women get vaccinated, Pfizer has predicted the U.S. could prevent as many as 20,000 infant hospitalizations a year and 320,000 doctor visits.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA approves 1st maternal RSV vaccine to help protect infantsThe U.S. Food and Drug Administration has approved the first maternal vaccine intended to help protect newborns against respiratory syncytial virus (RSV).
Weiterlesen »
US FDA approves Pfizer's maternal RSV vaccine to protect infantsThe U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.
Weiterlesen »
FDA approves first RSV vaccine for pregnancy to protect newbornsExpectant parents could soon have another new option this fall to protect their newborns from RSV, the most common cause of hospitalization in American infants.
Weiterlesen »
FDA approves Pfizer maternal RSV vaccine for infantsPfizer hopes that its respiratory syncytial virus vaccine will be available to the public by the end of October or the beginning of November.
Weiterlesen »
Pfizer maternal RSV vaccine gets FDA approvalNew shot designed to protect babies against leading cause of hospitalization is expected to be available this fall.
Weiterlesen »